• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Spanish Mobile Network Yoigo Launches Telemedicine Service Doctor Go

Share:

March 31, 2021

Spanish mobile operator, Yoigo, part of the telecommunications MásMóvil group brand, has launched a family package telemedicine service for its customers.

At €6 per month, the Doctor Go telemedicine service offers video-consultations with family doctors and specialists, as well as telepharmacy services for electronic prescriptions and the delivery of medicines.

WHY IT MATTERS

Available from last week on Android and IOS platforms, the service covers two adults and all children within a family unit. The initiative aims for immediate round-the-clock medical care, which includes a chat platform with specialists, access to the more than 40,000 professionals in the Quirón network, booking of COVID-19 testing and electronic prescriptions with shipping delivery of medicines, with discounted courier costs.

The initiative also provides wellness services, offering consultations with specialists in nutrition, personal training, and psychology. Yoigo also plans to provide access to face-to-face care through its agreement with the QuironSalud group.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Albert Castells, CEO of Spanish health insurance provider, iSalud told MobiHealthNews: “I think [the initiative] has all the ingredients to be successful because they have achieved something new. Its value proposition covers both the immediate need of the users allowing them to get an answer in two clicks from different specialists on your smartphone, and also to have the best medical offer in all the country.

“They have done that by onboarding specialised partners such as the leading Health Group in Spain, QuironSalud, and the leading eHealth specialized company, Meetingdoctors. And it is a matter of fact that MásMóvil is a success case in Spain, and has all the knowledge, brand, and customer database to make this project a great success.”

THE LARGER CONTEXT

The WHO recently praised telemedicine services for showing promising progress in helping those with chronic conditions during COVID-19. Through the Simple app, WHO and its partners in India have increased the use of telemedicine to offer consultations and prescriptions via phone.

ON THE RECORD

Castells told MobiHealthNews: “We all have noticed and understood the value of telemedicine and its use and penetration in the market has been increased due to COVID-19. That allows citizens to have more access than ever to telemedicine services, so they have tried and now they are willing to use it again.

“Telemedicine services have been led by the private sector over the public sector so far. Specifically, health insurance companies, health, and care providers started offering these services, most of them through partnering with specialized companies such as Meetingdoctors, which provide them the technological solution and the online medical team in a white-label model. Other ehealth players are directly offering B2C solutions.

“After the arrival of COVID-19, more companies from different sectors have approached the digital health market. Telco, banking, utilities, pharma are some interesting examples.”

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Antidote Health Secures $22M to Expand Telehealth Platform for Primary Care, Mental Health, Hypertension CareAntidote Health Secures $22M to Expand Telehealth Platform for Primary Care, Mental Health, Hypertension Care
  • Novus Finalizes Acquisition of Anelixis to Further Develop AT-1501Novus Finalizes Acquisition of Anelixis to Further Develop AT-1501
  • Taiwanese Firms Develop Gamified Mobile Health, Fitness AppTaiwanese Firms Develop Gamified Mobile Health, Fitness App
  • Foamix Announces OrbiMed’s Support of Merger with Menlo TherapeuticsFoamix Announces OrbiMed’s Support of Merger with Menlo Therapeutics
  • Imprivata, VMware Partner to Give Clinicians Password-Free Access to Any AppImprivata, VMware Partner to Give Clinicians Password-Free Access to Any App
  • COVID-19 Pandemic Further Exposes Systemic Racism…COVID-19 Pandemic Further Exposes Systemic Racism…
  • Lean on Your Connected Community of Care in Times of CrisisLean on Your Connected Community of Care in Times of Crisis
  • Boehringer Ingelheim Enhances Oncology R&D with Novel MacroDel Delivery Technology Via Acquisition of ICD TherapeuticsBoehringer Ingelheim Enhances Oncology R&D with Novel MacroDel Delivery Technology Via Acquisition of ICD Therapeutics

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications